From AHLA’s Life Sciences Practice Group: Dispensing Compounded Drugs from a 503B Outsourcing Facility and the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act
- November 06, 2024
You must be logged in to access this content.